MedPath

Study on the efficacy of alternate day mizoribine pulse therapy for lupus nephrits

Not Applicable
Conditions
lupus nephritis
Registration Number
JPRN-UMIN000000754
Lead Sponsor
Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences,University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1)Pregnant women or lactating mothers 2)Patients having complications such as marrow suppression, infectious diseases, ulcer disease 3)GFR < 30 ml/min 4)Patients with allergy with Mizoribin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath